Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT07184593
Eligibility Criteria:
Inclusion Criteria:
* Admission to the intensive care unit (ICU) within the past 24 hours.
* Patient must meet one of the following conditions:
Sepsis, defined according to SEPSIS-3 criteria.
Septic shock, defined according to SEPSIS-3 criteria.
Cardiogenic shock, classified as Stage C according to the Society for Cardiovascular Angiography and Interventions (SCAI).
Severe trauma requiring transfusion of four or more units of red blood cells within six hours.
Acute brain injury requiring invasive neuromonitoring.
Post-cardiac arrest with at least 15 minutes of no or low perfusion.
Severe acute pancreatitis requiring ICU-level care.
\- Presence of an arterial or central venous catheter to allow blood sampling.
Exclusion Criteria
* Patient who has expressed opposition to participate.
* Age younger than 18 years.
* Imminent death with an expected survival of less than 24 hours.
* Presence of therapeutic limitations (e.g., no indication for intubation).
* Active cancer.
* Absence of the required vascular access.
* ICU admission longer than 24 hours prior to screening.
* Readmission of a previously enrolled patient.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07184593
Study Brief:
Protocol Section:
NCT07184593